Not applicableStudy completedNCT07171827
What this trial is testing
Anti-CD30 (Brentuximab Vedotin) With AVD Versus ABVD Chemotherapy Protocol Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma
Who this might be right for
Anti-CD30BrentuximabDoxorubicin+4 more
Helwan University 60